ArticleEJHaem2026

Durable MRD-Negative Remission With Blinatumomab and Venetoclax in Heavily Pretreated Relapsed/Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Mohammad Shahzaib Qadir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.